Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
Alexander C. J. van Akkooi(The University of Sydney), Mike Kliffen(Maasstad Ziekenhuis), Alexander M.M. Eggermont(University Medical Center Utrecht), Cornelis Verhoef(Erasmus MC Cancer Institute), Paul Schmitz(University Hospital Regensburg), Johannes H. W. de Wilt(Radboud University Nijmegen), A.N. van Geel(Erasmus MC)
Cited by 277
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k